8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
1/93
Presented by:Date:
Location:
ChildhoodChildhood
vaccines at workvaccines at workin Canadain Canada
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
2/93
The case for immunization
Vaccine safety
Vaccines in Canada
Myths, facts and commonly asked questions
Public policy
esources
Presentation overviewPresentation overview
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
3/93
!ased on Your Childs Best Shot:
A parents guide to vaccination
"#rdedition, $%%&'
For updates including position statements from the
CPS Infectious Diseases and Immuniation Committee
and current information for parents! "isit the CPS
we#sites$ www.cps.caand www.caringforkids.cps.ca
%e"iewed #y the CPS Infectious Diseases andImmuniation Committee. &ead re"iewers$
Dr. 'o# 'artolussi and Dr. Dorothy (oore.
Sources of informationSources of information
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
4/93
The case forThe case for
immunizationimmunization
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
5/93
Vaccines save lives:A public health success story Vaccines are safeand effective: The diseases they prevent can
cause permanent disability or even death
Its a small world: Travelcan spread rare diseases quickly Many vaccine-preventable diseases have no effective treatments For some diseases like tetanus infection does not produce
immunity: Vaccines produce immunity
! "ast but not least !
Why we immunizeWhy we immunize
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
6/93
Vaccines protect everyone
Directly:the person vaccinated and
Indirectly:people who are vulnerable to disease e#$ babieschildren the elderly people with a weak immune system Vaccines keep communities healthier: children in school
parents workin# people interactin# normally
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
7/93
Immunology 101 %acteria and viruses have unique proteins and polysaccharides
&comple' su#ars( on their sur)aces called antigens
Immune system tar#ets anti#ens usin# antibodiesand lymphocytes Lymphocytes &a type o) white blood cell(* include %-cells T-cells
and memory cells emory cells enable the immune system to reco#ni+e #erms it has
seen be)ore creatin# immune memory
How vaccines workHow vaccines work
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
8/93
) Long!lasting immunity depends on memory cells"Immune
memory is the ability the immune system acquires to identi)y the
presence o) a #erm and destroy it T#o #ays to achieve immunity:,atural in)ection or
immuni+ation
$ %atural infectioncauses illness and can lead to complications
permanent dama#e even death
$ Vaccinesprotect without causin# severe illness
ImmunityImmunity
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
9/93
Types of (accines
T)P* + V-CC./* *0-MPL*1
*illed! intact "irus Inacti"ated polio "accine! hepatitis + "accine
*illed! intact #acteria ,ral cholera "accine -Duoral/
*illed! disrupted "irus Influena "accine
&i"e! attenuated -weaened/ #acteria ,ral typhoid "accine! 'C "accine -for '/
&i"e! attenuated -weaened/ or genetically modified "irus (easles! mumps! ru#ella! "aricella! yellow fe"er"accines oral polio! rota"irus "accines intranasalinfluena "accine
Purified #acterial protein +cellular pertussis "accine! in3ecta#le typhoid "accine
Purified #acterial polysaccharide -comple4 sugar/ Haemophilus influenzaetype #! pneumococcal andmeningococcal "accines
Purified "iral protein 5epatitis ' "accine! human papilloma"irus "accine
Inacti"ated #acterial to4in Diphtheria and tetanus to4oids
Immunology of vaccinesImmunology of vaccines
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
10/93
D.1*-1*-V*-2* /3M!* + C-1*1 -/D *L-T*D D*-T41-per year/
!efore Vaccine -fter Vaccine
Diphtheria 12!000 cases with 1!000 deaths 067 cases with 0 deaths
Tetanus 80697 cases with :0670 deaths 062 cases and no deaths since 1;;1
Pertussis Polio 2!000 cases in last epidemic in 1;7; 0
4ib 1!700 cases of meningitis and 1!700 cases ofinfections of #lood! #one! lungs! sin! 3oints
+#out ! or
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
11/93
2010 Canadian Paediatric Society I www.cps.ca
D.1*-1*-V*-2* /3M!* + C-1*1 -/D *L-T*D D*-T41-per year/
!efore Vaccine -fter Vaccine
Pneumococcus
4epatitis ! 20!000 new cases! with :>0@700deaths
? 1!000 cases
Menin5ococcus 200@:00 cases! with 20@:0 deaths Program too new to see full effect
4epatitis - 10!000@20!000 cases Program too new to see full effect
4uman papilloma(irus"4PV'
1!
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
12/93
DISEASE EFFECTS OF DISEASE SIDE EFFECTS OF VACCINE
Diphtheria
Severe sore throat, marked weakness,nerve damage, heart failure !eath in"#$ of cases
!TaP vaccine% $ of infants have localredness, 'ain( ) *$ have fever( moreredness and swelling with +ooster at -.years
Tetanus To/in a0ects nerve endingsleading to'ainful muscle s'asms and seizures
See a+ove for !TaP 1ocal redness and 'aincommon with adult +ooster
Pertussis Severe s'asms of cough lasting 2-.weeks, 'neumonia, convulsions 3raindamage or death in " of every ##infants
See a+ove for !TaP The risk of +rain damageafter 'ertussis vaccine is too small to +emeasured
Polio 4uscle 'aralysis in " out of "## 'ersonsinfected with 'olio !eath in severecases
IPV 5o risk of disease from vaccine 6ivencom+ined with !TaP 7see a+ove for sidee0ects8
Hib 4eningitis kills in *$ of cases and leadsto +rain damage and deafness in "#-
"*$ of survivors
6iven in com+ination with !TaP9IPV 7seea+ove for side e0ects8
Measles Severe +ronchitis, high fever, rash for :-" days( death in " 'er ",### cases(ence'halitis in " 'er ",### cases
6iven com+ined with mum's and ru+ellavaccines 744;8 *-"#$ have fever with orwithout rash
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
13/93
2010 Canadian Paediatric Society I www.cps.ca
DISEASE EFFECTS OF DISEASE SIDE EFFECTS OF VACCINE
Rubella =ever, swollen glands, rash 5osym'toms in a+out *#$ of cases
Severe damage to fetus if motherinfected during ?rst trimester of'regnancy
6iven com+ined with mum's andru+ella vaccines 744;8 *-"#$ have
fever withor without rash
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
14/93
&mallpo' has been eradicated",o cases anywhere in the world
since ./0/$ 1hildren are no lon#er vaccinated a#ainst smallpo' (aralytic polio eliminated from most of the #orld"Today
endemic in only )our countries* A)#hanistan India ,i#eria
2akistan3 1ases dropped )rom 456666 in ./77 to .868 in 966/
3 :ecent outbreaks in )ormer ;oviet republics o) Ta
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
15/93
*hen vaccination rates decline) rates of disease increase >'ample* In the late ./76s )ormer ;oviet =nion states saw vaccine
supplies disrupted collapse o) their public health system and
socioeconomic instability
:esult* decrease in childhood immuni+ation rates ?iphtheria epidemic )ollowed* more than .56666 cases and more
than @666 deaths in the newly independent and %altic states Mass vaccination pro#ram eventually controlled the epidemic Lesson: +omplacency can be fatal
Why we 7still8 immunizeWhy we 7still8 immunize
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
16/93
utbreaks occur )or di))erent reasons such as*(ublic doubt:In the early 9666s a )lawed autismBMM: study in the
=$C$ led to decline in measles vaccination
3 :esults* Increase in local measles in)ection rates and deaths and
spread o) measles to other countries
3 "esson* Vaccination must continue to prevent disease outbreaksTravel:Measles and mumps have been introduced into 1anada by
travellers causin# local outbreaks9667* 2olio spread by travellers )rom the @ countries where it remains
endemic to 96 others3 "esson* Its a small worldD Travel can spread a rare disease very
quickly
2010 Canadian Paediatric Society I www.cps.ca
Why out+reaks 7still8 occurWhy out+reaks 7still8 occur
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
17/93
2010 Canadian Paediatric Society I www.cps.ca
*aning immunity:"ar#e mumps outbreak in 9660-67$ ;tarted in,ova ;cotia spread to ,ew %runswick and Alberta with sporadic
cases elsewhere
Mainly a))ected 96 to 9/-year-olds in school settin#s
2rompted recommendation )or a second dose o) vaccine )or hi#h
school colle#eBuniversity students who had received only one dose in
early childhood
Lesson: There may be a need for a second ,booster- dose of
mumps vaccine
Why out+reaks 7still8 occur (contd)
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
18/93
Vaccine safetyVaccine safety
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
19/93
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
20/93
%3+I:,ational Advisory 1ommittee on Immuni+ation makes
recommendations to the 1hie) 2ublic Eealth ))icer +I+: 1anadian Immuni+ation 1ommittee assesses ,A1I
recommendations and advises on operational plans (rovinces4territoriesuse ,A1I and 1I1 recommendations to
develop immuni+ation pro#rams ,A1Is Canadian Immunization Guide: Geb-based #uidelines
)rom the 2ublic Eealth A#ency o) 1anadapublished every @ years
&most recent edition 96.6( at www$phac-aspc$#c$ca +anadian (aediatric &ociety:In)ectious ?iseases and
Immuni+ation 1ommittees position statements at www$cps$ca
;ecommendations for;ecommendations for
vaccine usevaccine use
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
21/93
3dverse events:Eealth e))ects occurrin# a)ter immuni+ation thatmay or may not be related to the vaccine
Mild adverse events such as )ever and swellin# at the in
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
22/93
+anadian 3dverse 5vents 6ollo#ing Immuni7ations &urveillance
&ystem +356I&&: :eceives reports )romdoctors nurses 3dvisory +ommittee on +ausality 3ssessment 3++3: :eviews all
reported cases o) serious adverse events I(3+T: Immuni+ation Monitorin# 2ro#ram A1Tive The Vaccine 3dverse 5vent 8eporting &ystem &V358&: 2ost-
marketin# sa)ety surveillance pro#ram in the =$;$ Institute of edicine I9) "&":Immuni+ation ;a)ety :eview
1ommittee /3+V& *;9:lobal Advisory 1ommittee on Vaccine ;a)ety
>ntities involved in>ntities involved in
monitoring vaccine safetymonitoring vaccine safety
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
23/93
Vaccines in CanadaVaccines in Canada
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
24/93
;outine childhood vaccines;outine childhood vaccines
a#ainst diphtheria tetanus pertussis
polio and bacterial in)ections
caused by Eib &Haemophilus
influenzaetype b( includin#
menin#itis &a brain in)ection( and
other serious in)ections 8: 2rotects a#ainst measles
mumps and rubella
;epatitis . vaccine
Varicella chickenpo' vaccine
&easonal influen7a ,flu- vaccine
Tdap: Tetanus diphtheria and
pertussis booster )or teens and
adults
2010 Canadian Paediatric Society I www.cps.ca
(neumococcal vaccine:2rotects
a#ainst bacterial in)ections caused byStreptococcuspneumoniaeincludin#
menin#itis pneumonia and ear
in)ections
eningococcal vaccine:2rotects
a#ainst bacterial in)ections caused byNeisseria meningitidis includin#
menin#itis and septicemia a serious
blood in)ection
;(V vaccine: 2rotects a#ainst human
papillomavirus types that cause
cervicalBva#inal cancer and #enitalwarts
8otavirus vaccine: 2revents
rotavirus diarrhea
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
25/93
Additional vaccines or aAdditional vaccines or a
Bcatchu'D scheduleBcatchu'D schedule 1hildren with certain chronic conditions or who travel outside o)
,orth America may require additional vaccines 1hildren new to 1anada may not have received vaccines which are
routine here 1hildren who move within 1anada may miss a dose o) vaccine
because schedules are not uni)orm across the country
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
26/93
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
27/93
PrecautionsPrecautions
Delay#ivin# vaccine i) child has* Moderate to severe illness 2eople treated with blood products should not #et a live vaccine
&e#$ measles mumps rubella varicella( )or 4 months or more$
?ependin# on the blood product and dose received these vaccinesmay not work
Don=t delayvaccination because o) minor illness &e#$ a cou#h or
cold with or without )ever($
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
28/93
1aused by a to'in made by bacteria that in)ect the nose throat orskin
1an cause breathin# problems heart )ailure nerve dama#e kidney
)ailure About . person in .6 dies ;pread by close direct contact withdroplets )rom a cou#h or
snee+e %e)ore ./66 one o) the main causes o) childhood death$ An
estimated .9666 casesByear in 1anada with .66 deaths ./9@* /666 cases in 1anada :outine immuni+ation o) 1anadian children a)ter ./46 ;ince ./74*
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
29/93
Inactivated bacterial to'in
iven with tetanus acellular pertussis polio and Eib vaccines as
5-in-. Also #iven with tetanus and pertussis as a booster in adolescence Also #iven with tetanus as a boosterHrecommended every .6
years )or adults 1ommon local reactions* redness swellin# pain and tenderness at
the in
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
30/93
1aused by a to'in made by bacteria that block normal control o)nerve re)le'es in the spinal cord* also known as lock
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
31/93
Inactivated bacterial to'in
Most o)ten #iven with diphtheria acellular pertussis polio and
Eib vaccines as 5-in-. Also #iven with diphtheria and pertussis as a booster in
adolescence Also #iven with diphtheria as a boosterHrecommended every
.6 years )or adults 1ommon local reactions* redness swellin# pain and tenderness
at the in
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
32/93
:espiratory in)ection caused by bacteria* whoopin# cou#hJ 1auses severe cou#hin# spells )ollowed by a whoopJ sound "asts 8 to .9 weeks 96-46K o) in)ants with pertussis will be hospitali+ed . in @66 in)ants will have brain dama#e Very contagious: &pread by close) direct contact #ithdroplets
from a cough or snee7e
%e)ore vaccine* 46666-56666 casesByear with 56-.66 deaths Today* 4666 cases in 1anada with about 5 deaths each year
8ecent years: increasing number of cases in teens) youngadults" (ertussis still a common cause of chronic cough
> ? #eeks in teens and adults
2010 Canadian Paediatric Society I www.cps.ca
PertussisPertussis
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
33/93
Ghole-cell vaccine introduced in 1anada in ./@4
Acellular pertussis replaced whole-cell vaccine in .//0 2uri)ied bacterial proteins* )ewer side e))ects iven with diphtheria tetanus polio and Eib vaccines as 5-in-. 3lso given to older children) teens and adults as a booster)
combined #ith Td
Immuni7ing parents) adults #orking #ith children protects
babies too young to be fully immuni7ed
?oes not prevent in)ection in everyone but e))ective in reducin#
severity o) illness and the risk o) complications
Minor local side e))ects are common nly contraindication* anaphylactic or other serious aller#ic
reaction to a previous dose o) the vaccine
Pertussis vaccine
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
34/93
1aused by poliovirus %e)ore ./55 a common in)ection in 1anada Most in)ections asymptomatic &no symptoms( or mild but .-5K
cause menin#itis and .K paralytic polio Virus in throat and )eces o) people who are in)ected* spreads by
close direct contact with throat secretions and indirect contact
&e#$ contaminated hands water )ood( ./5/* last epidemic in 1anada with 9666 cases o) paralytic polio 1hildren a#es 5 to / years the most a))ected$
./7/* last case o) paralytic polio due to poliovirus in 1anada 9667* still seen re#ularly in @ countries and can be spread by
travellers
PolioPolio
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
35/93
I2V &inactivated polio vaccine(* killed intact virus
iven with diphtheria tetanus pertussis and Eib vaccines as5-in-.
2V &oral polio vaccine(* live attenuated virus$ ,ot used in
1anada since .//0-/7 but still used in many countries ;ide e))ects o) I2V are rare >))ective and lon#-lastin#* A)ter 4 doses .66K o) in)ants develop
antibodies a#ainst all 4 types o) poliovirus nly contraindication to I2V* an anaphylactic or other serious
aller#ic reaction to a previous dose o) the vaccine
Polio vaccine
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
36/93
,ot to be con)used with seasonal in)luen+a or )luJ
Loun# children most at risk =ntil ./75 the most common cause o) bacterial
menin#itis in 1anada* .566 casesByear in children
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
37/93
2uri)ied bacterial polysaccharide linked to a protein carrier such
as diphtheria or tetanus to'oid iven with diphtheria tetanus pertussis and polio vaccines as
5-in-. (rotects child against ;ib and helps decrease spread among
children generally
"ocal redness and pain in 5-.5K o) in)ants nly contraindication* anaphylactic or other serious aller#ic
reaction to a previous dose o) the vaccine
Hi+ vaccine
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
38/93
Streptococcus pneumoniae* most common cause o)menin#itis and other invasive serious bacterial
in)ections in children in 1anada especially in children
9 years o) a#e lder children teens and adults with certain chronic
conditions are also at hi#her risk In)ection starts in nose or throat$ any people are
asymptomatic carriers have no symptoms
,ot hi#hly conta#ious but spreads throu#h close direct
contact* children in day care more at risk "ocal in)ections* acute otitis media acute sinusitis
acute bronchitis pneumonia Invasive in)ections* menin#itis bacteremia septicemia
endocarditis septic arthritis osteomyelitis peritonitis any pneumococci are becoming antibiotic!resistant
- recent
success story
Since routine
"accination of
infants #egan in
2007$ ;:=
decrease inin"asi"e disease
in children ? 2
years old
Indirect effect$
decreased
e4posure has ledto a ;1=
decrease in
in"asi"e disease
in the elderly
2010 Canadian Paediatric Society I www.cps.ca
Pneumococcal diseasePneumococcal disease
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
39/93
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
40/93
Neisseria meningitides*cancause menin#itis bacteremia septicemia andother invasive in)ections
%e)ore vaccine 966-@66 cases o) invasive in)ectionByear in 1anada with
96-@6 deaths$ ;ince 966. rate in 1anada has decreased to about 966
casesByear
2eople with certain chronic diseases are at hi#her risk ?eath )rom serious disease in 5K o) cases even with treatment and can
occur within 8-.9 hours o) )irst si#ns o) illness Menin#ococcal bacteria are )ra#ile and in)ections are not very conta#ious ost spread occurs via healthy carriersHabout . in 5 adolescents and
adultsHby close direct contact with mouth secretions respiratory droplets
5 sero#roups &A % 1 L and G.45( cause nearly all in)ections in 1anadawith roups % and 1 causin# the most illness
In)ections caused by sero#roups A 1 L and G.45 will likely drop now
that con
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
41/93
A routine booster dose o) either con
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
42/93
;evere viral in)ection$ 1auses hi#h )ever runny nose cou#h conncephalitis* . in .666 cases can lead to brain dama#e or death :are cases* ;;2> &subacute sclerosin# panencephalitis( ;ighly contagious: &preads by direct contact and through the air" /erms
become airborne in a cough or snee7e
%e)ore vaccine* lar#e epidemics every 9-4 years$ Most children had measlesusually by .7 years o) a#e
466666 casesByear in 1anada with 466 deaths and 466 children with brain
dama#e Vaccine approved in ./84N two-dose schedule in .//8-/0 966.-68* )ewer than 96 casesByear
?00@ outbreak in 2uebec: A< cases) almost all in persons #ho refused
vaccination
?00B outbreak in 9ntario: in over
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
43/93
"ive attenuated &weakened( virus iven with mumps and rubella vaccines as MM: or with varicella as MM:-V 9 doses required since about 5K o) vaccinated children remain unprotected a)ter
)irst dose Mild side e))ects* )ever &in 5-.6K o) children( or rash &in 9K o) children( ;evere adverse events rare* risk o) encephalitis is less than . case per one million
doses ,oevidence o) links to other diseasesBdisorders &such as autism developmental
delay 1rohns disease ulcerative colitis(
1ontraindications* Aller#ic reaction to neomycin #elatin or a previous dose o) the vaccine 1ertain immune system disorders 2re#nancy
2recautions* ?elay vaccine )or moderate to severe illness ?elay vaccine )or 4 months or more )or anyone who has received blood products
as the vaccine may not work
4easles vaccine
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
44/93
Viral in)ection that can cause )ever headache and swellin# o) salivary#lands around the
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
45/93
"ive attenuated virus
iven in combination with measles and rubella vaccines as MM: orwith varicella as MM:-V* 9 doses
;ide e))ects are rare* Menin#itis reported to occur in . case per 766666
doses
1ontraindications* Aller#ic reaction to neomycin #elatin or a previous dose o) the vaccine 1ertain immune system disorders 2re#nancy
2recautions* ?elay vaccine )or moderate to severe illness ?elay vaccine )or 4 months or more )or anyone who has received blood
products as the vaccine may not work
4um's vaccine
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
46/93
Viral in)ection also known as erman measles 1an lead to )ever sore throat swollen #lands rash =sually mild in children$ More severe in teens and adults* arthral#ias
arthritis are common in adults In pre#nancy can in)ect the )etus causin# severe disabilities* con#enital
rubella syndrome &1:;( which can result in heart disease dea)ness
cataracts mental retardation ;preads by direct contact with mouth or nose secretions and droplets )rom
a cou#h or snee+e$ "ess conta#ious than chickenpo' or measles %e)ore vaccine 75K o) children had rubella by a#e 96* 956666
casesByear with 966 cases o) con#enital rubella syndrome
Gorldwide epidemic in ./8@* In =$;$ O46666 babies in)ected durin# )irst96 weeks o) pre#nancy$ ) those O96666 cases o) 1:; and 7666 deaths
;ince routine immuni+ation be#an in ./76* nly 6-4 babies with 1:; are
born in 1anada each year to unvaccinated mothers
;u+ella;u+ella
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
47/93
"ive attenuated virus iven to in)ants with measles and mumps vaccines as MM: or with
varicella as MM:-V* 9 doses
1ontraindications* Aller#ic reaction to neomycin #elatin or a previous dose o) vaccine
1ertain immune system disorders 2re#nancy
2recautions* ?elay vaccine )or moderate to severe illness
?elay vaccine )or 4 months or more )or anyone who has received bloodproducts as the vaccine may not work
;u+ella vaccine
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
48/93
Gomen o) child-bearin# a#e should be tested )or immunity to rubella
be)ore )irst pre#nancy Gomen not immune and not pre#nant should be vaccinated I) pre#nant and not immune delay vaccine but mother should be
vaccinated as soon as possible a)ter delivery )or )uture protection ;ide e))ects o) vaccine rare in in)ants
95K o) vaccinated women e'perience
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
49/93
1aused by varicella-+oster virus
Fever headache aches and pains and itchy rash =sually a mild &but costly( disease* 2arents o)ten stay home )or
4 daysN 46-85K o) children are brou#ht to a clinic or hospital 1an lead to complications such as pneumonia bacteremia or
severe skin in)ections Illness is more severe and complications more common in
teena#ers and adults ;evere cases can pose serious health risks especially )or newborn
babies adults or anyone with a weakened immune system ;ighly contagious: Viruses from the throat and scratched
skin lesions spread easily through the air" 3lso spreads by
contact #ith rash
1onta#ious 9 days be)ore rash appears until the last blister has
crustedHusually about 5 days a)ter rash be#ins Virus remains dormant in the nervous system and can be
reactivated later to cause shin#les &+oster(
Varicella 7chicken'o/8Varicella 7chicken'o/8
2010 Canadian Paediatric Society I www.cps.ca
- recent success
story
'efore "accine
E
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
50/93
"ive attenuated virus 75-/6K e))ective in preventin# chickenpo' and .66K e))ective in preventin# moderate to
severe disease 9 doses o) vaccine now recommended )or all children one year o) a#e &previously
9 doses #iven only to people vaccinated at P .4 years o) a#e( ?uration o) protection at least 96 yearsHpossibly li)elon# Mild local reactions in about 96K o) children Vaccine-modi)ied disease does occur but is uncommon and the illness less severe Transmission o) vaccine virus )rom healthy vaccinated children to susceptible contacts is rare iven as varicella vaccine or in combination as MM:-V
1ontraindications* Aller#ic reaction to neomycin or #elatin or to a previous dose o) the vaccine 1ertain immune system disorders 2re#nancy
2recautions* ?elay vaccine )or moderate to severe illness ?elay vaccine )or 4 months or more )or anyone who has received blood products as the
vaccine may not work
Varicella vaccine
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
51/93
Viral in)ection o) the liver Eal) o) in)ected people have no symptoms$ ther hal)
become ill* )ever )ati#ue loss o) appetite and
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
52/93
2uri)ied viral protein
Available alone or with hepatitis A vaccine ,o uni)orm schedule )or routine immuni+ation but school pro#rams are
widespread$ In some provincesBterritories vaccine #iven durin# in)ancy :ecommended )or*
3 ,ewborns o) mothers who have hepatitis %
3 1hildren attendin# child care pro#rams and their care#ivers
3 All children be)ore or in early adolescence
3 2eople travellin# to countries where there is a risk o) contractin#
hepatitis %
3 1hildren under 0 years o) a#e who have immi#rated to 1anada )rom
areas with hi#h rates o) hepatitis %
3 Eousehold or close contacts o) an in)ected person3 2eople who are at hi#her risk o) contact with blood such as*
health care workerspatients on hemodialysis &treatment )or kidney disease(
He'atitis 3 vaccine
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
53/93
In)ection o) the liver caused by hepatitis A virus Many youn# children have no symptoms or )ever only but they are still
conta#ious and can in)ect others Adolescents and adults more likely to become ill In)ection causes )ever )ati#ue loss o) appetite nausea vomitin# and
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
54/93
Cilled intact virus vaccine
,ot on the routine childhood immuni+ation schedule e'cept in Quebec /5K e))ective in preventin# in)ection ,ot recommended )or children . year o) a#e For lon#er protection 9 doses #iven 8 to .9 months apart are recommended :ecommended )or*
3 2eople travellin# to places where hepatitis A is common includin#
children o) new 1anadians who visit relatives abroad
3 2eople with chronic liver disease or hemophilia
3 1ommunities lackin# adequate sanitation or sa)e water supply
3 2eople in ha+ardous occupations &e#$ relie) workers sewer workers(or
with riskier li)estyles &e#$ illicit dru# users men who have se' with men(
3 1lose contacts o) known cases "ocal reactions* mild pain and redness at in
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
55/93
2010 Canadian Paediatric Society I www.cps.ca
In)luen+a virus causes yearly epidemics o) respiratory illness
1an cause periodic pandemics when the virus chan#es suddenly and no oneis immune
?urin# outbreaks hospitali+ation rates )or in)ants and the elderly increase ;ighly contagious: spreads in respiratory secretions) on contaminated
hands) droplets from a cough or snee7e) and on contaminated obCects or
surfaces ;preads easily in schools and child care settin#s$ 1hildren brin# the in)ection
home to )amily members 1omplications o) )lu in youn# children can include* pneumonia otitis media
)ebrile sei+ures severe muscle in)lammation and encephalopathy Annual seasonal in)luen+a shot is recommended )or people at hi#h risk o)
complications )rom the )lu includin#*
3 all children a#ed 8 to 94 months and older children with certain chronic
disorders
3 parents siblin#s household contacts and care#ivers o) hi#h-risk children
Seasonal inEuenza 7Eu8Seasonal inEuenza 7Eu8
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
56/93
2010 Canadian Paediatric Society I www.cps.ca
Cilled disrupted virus with vaccine strains chan#in# every year
Virus chan#es every year* annual vaccination in )all needed to protecta#ainst seasonal )lu
First year o) immuni+ation* children / years old need 9 doses @ weeks
apart "ocal reactions in .6-56K o) recipients* soreness at in
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
57/93
A live attenuated intranasal vaccine &"AIV( licensed in 1anada in
96.6 ,ot yet )unded by any provinceBterritory or incorporated into any
public pro#ram "icensed )or all healthy children 9 years o) a#e and all healthy
persons youn#er than 5/ years o) a#e
&ome evidence that in children it #orks better than inactivated fluvaccine
Vaccine strains are adapted to #row only in the nasal passa#es where
they induce immunity but cannot invade the body The )lu strains vary each year and are the same ones included in the
inactivated vaccine
A new Eu vaccine
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
58/93
2010 Canadian Paediatric Society I www.cps.ca
In a pandemic*
In)luen+a virus chan#es suddenly spreads quickly around the world andno oneHor only a very small se#ment o) the populationHhas immunity
to the new virus 2opulations at risk o) developin# severe illness may be di))erent than
durin# yearly seasonal in)luen+a
;easonal in)luen+a vaccine is ine))ective a#ainst the new virus strain
Pandemic vs seasonal inEuenza
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
59/93
2010 Canadian Paediatric Society I www.cps.ca
lobal national and re#ional health authorities respond to a declared
pandemic by*.eing prepared" overnment health authorities worldwide*
3 activate pandemic plans )or health care workers and the #eneral public
to prevent spread and protect #roups most vulnerable to severe illness
3 conduct a##ressive messa#in# on how to minimi+e spread o) the new
strain &e#$ wash hands cou#h into a sleeve not hands and stay homei) ill() &urveillance" 2ositive cases are tracked monitored and reportedImmuni7ation"A pandemic in)luen+a vaccine intended )or at-risk
populations anywhere in the world is developed and tested*
3 vaccine becomes available in allotments not all at once3 new vaccines #o throu#h a sti)) approval process to ensure hi#h quality
Pandemic inEuenza vaccine
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
60/93
2010 Canadian Paediatric Society I www.cps.ca
Most common se'ually transmitted in)ection in 1anada 2revalence in 1anada* between ..K and 9/K Ei#hest rates o) E2V acquisition occur in the )irst 5 years )ollowin#
onset o) se'ual activity$ About 4 in @ se'ually active 1anadians are
in)ected at some point =sually no symptoms but E2V is the ma
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
61/93
2010 Canadian Paediatric Society I www.cps.ca
2uri)ied viral protein vaccine
9668* Vaccine approved )or use in 1anada in #irlsBwomen / to 98 years o)a#e
9660* Federal #overnment announced )undin# to implement E2V
immuni+ation pro#rams 96.6* Quadrivalent vaccine approved )or use in both )emales and males
a#es / to 98$ ,A1I reviewin# recommendations with a view to e'pandin#
school pro#rams to boys and youn# men %ivalent vaccine a#ainst E2V-.8 and -.7 and quadrivalent vaccine a#ainst
E2V-8 -.. -.8 and -.7 #enotypes 5ither vaccine needs to be given before the onset of se'ual activity)
bet#een the ages of A and 1 years of age
"ocal reaction* soreness at in
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
62/93
2010 Canadian Paediatric Society I www.cps.ca
"eadin# cause o) acute diarrhea in babies and youn# childrenworldwide* at least 96K o) all childhood #astroenteritis caused by
rotavirus Almost all children are in)ected by 5 years o) a#e utbreaks usually happen February to May 1auses )ever vomitin# severe watery diarrhea and rapid dehydration
in youn# children who cannot keep down enou#h )luid ?eath is rare in Gestern countries but in the developin# world rotavirus
kills as many as 5 in .66 children be)ore their 5thbirthday ;ighly contagious before and after symptoms develop* viruses in
stool spread easily by contact with contaminated hands ob
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
63/93
2010 Canadian Paediatric Society I www.cps.ca
;otavirus vaccine 96.6* :ecommended )or routine use in 1anada
Two live attenuated &weakened( oral vaccines available )or preventin# rotavirus#astroenteritis in in)ants 8 to 49 weeks o) a#e %oth sa)e e))ective and #iven orally in liquid )orm iven in 9 or 4 doses usually at 9 @ and 8 months o) a#e$ 6irst dose must be
given bet#een E!1F #eeks of age) and all doses completed before B months of
age
Doses are given at least F #eeks apart
1ontraindications* Anaphylactic or other serious aller#ic reaction to a previous dose o) the vaccine A history o) bowel obstruction ?isorders o) the immune system &as sa)ety data is not yet available(
2recautions A weakened immune system ?elay vaccine )or moderate to severe illness especially diarrhea
h f d
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
64/93
4yths, facts and4yths, facts and
commonly askedcommonly askedFuestionsFuestions
2010 Canadian Paediatric Society I www.cps.ca
4 th4 th
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
65/93
63+T&:
Vaccinations are )requently #iven in early in)ancy %rain abnormalities are o)ten not reco#ni+able this early$
?ia#nosis o) cerebral palsy mental retardation or developmental
delay are usually not made until a child is several months old An abnormality is o)ten reco#ni+ed only a)ter one or more
vaccine doses have been #iven but this does not mean the
vaccine caused the problem
4yth%4yth%Vaccines can cause +rain damage and otherVaccines can cause +rain damage and other
illnesses that canGt otherwise +e e/'lainedillnesses that canGt otherwise +e e/'lained
2010 Canadian Paediatric Society I www.cps.ca
4 th4 th
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
66/93
63+T:
,ot so$ There were )ewer deaths )rom some diseases &e#$ measles
diphtheria( because o) improved nutrition and health care but )or
other diseases &e#$ polio( healthy children continued to die or
become disabled
4yth%4yth%;ates of disease were declining +efore the;ates of disease were declining +efore the
use of vaccinesuse of vaccines
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
67/93
63+T:
Vaccination is not compulsory$ %ut not vaccinatin# puts others at
risk o) disease compromisin# their ri#hts
4yth%4yth%Com'ulsory vaccination violates civil rightsCom'ulsory vaccination violates civil rights
2010 Canadian Paediatric Society I www.cps.ca
4 th4 th
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
68/93
63+T:
,o in)ection acts as a #eneral stimulus to the immune system$
Measles and in)luen+a actually suppressthe immune system$
2010 Canadian Paediatric Society I www.cps.ca
4yth%4yth%Infections like measles stimulate theInfections like measles stimulate the
immune systemimmune system
h i hTh ti th 44;
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
69/93
.//7* The Lancetpublished a study led by ?r$ Andrew Gake)ield
which appeared to link vaccine with autism 1aused MM: immuni+ation rates to drop in %ritain measles
outbreak The study itself has since been thoroughly discredited March 966@* .6 o) ori#inal studys .4 authors published a retraction o)
their interpretation in The Lancet Ranuary 96.6* =$C$s re#ulatin# eneral Medical 1ouncil )ound
Gake)ield had acted dishonestly and irresponsiblyJ in doin# his
research February 96.6* >ditors at The Lancet)ully retracted Gake)ields paper
)rom the published record May 96.6* Gake)ield was struck o)) the medical re#istry in the =$C$ Many recent lar#e studies by ma
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
70/93
Thimerosal* A preservative used to prevent #rowth o) bacteria and )un#i in
multidose vials o) vaccines ,ot added to sin#le-dose vaccines In the body metaboli+ed to ethyl mercury .///* 1oncern in the =$;$ about possible to'icity o) ethyl mercury 966@* =$;$ Institute o) Medicine review )ound no evidence o) relationship
between thimerosal and autism or any other neurolo#ical disease$ Morerecent studies con)irm their )indin#s ?ia#noses o) autism continued to increase a)ter thimerosal was removed
)rom childhood vaccines Thimerosal is a component in only one vaccine )or routine immuni+ation o)
1anadian childrenH)lu vaccineHwhich is #enerally marketed in multidose
vials A thimerosal-)ree stable in)luen+a vaccine is also available )or children ;till used as a preservative in certain vaccines produced )or adults not
children
The thimerosal mythThe thimerosal myth
2010 Canadian Paediatric Society I www.cps.ca
C l k d tiCommonly asked Fuestions
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
71/93
2010 Canadian Paediatric Society I www.cps.ca
%reast milk is the ideal )ood )or babies$ It provides important
nutritional and immune )actors and contains antibodies that help
prevent some in)ections$
Eowever this protection is incomplete and breast milk does notprotect a#ainst all in)ections preventable by vaccines
%reast)eedin# is not an alternative to immuni+ation and does not
enhance responses to vaccines 2rotection decreases rapidly when breast)eedin# stops
Commonly asked FuestionsCommonly asked FuestionsWonGt +reastfeeding 'rotect +a+ies fromWonGt +reastfeeding 'rotect +a+ies from
infectioninfection
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
72/93
2010 Canadian Paediatric Society I www.cps.ca
Immunity a)ter most vaccines is very vaccine-preventable in)ection can cause serious harm
Immune response to natural in)ection may be too late to preventserious harm
Gith vaccines the immune system is stimulated to develop
protection a#ainst the disease without )ull-blown in)ection
Commonly asked FuestionsCommonly asked FuestionsIs BnaturalD immunity more e0ectiveIs BnaturalD immunity more e0ective
Commonly asked FuestionsCommonly asked Fuestions
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
73/93
2010 Canadian Paediatric Society I www.cps.ca
,o evidence that side e))ects are more common in in)ants or babies
than in older children ?elayin# vaccination leaves very youn# children at risk o)
complications and death )rom common diseases &e#$ pertussis Eiband pneumococcal in)ections are more severe )or babies(
Commonly asked FuestionsCommonly asked FuestionsShouldnGt vaccines +e delayed until childrenShouldnGt vaccines +e delayed until children
are older and there is less risk of sideare older and there is less risk of sidee0ectse0ects
Commonly asked FuestionsCommonly asked Fuestions
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
74/93
2010 Canadian Paediatric Society I www.cps.ca
In)ants can respond to about .6666 di))erent anti#ens at any one
time %acteria and viruses e'pose an in)ant to lar#e numbers o) anti#ens
at onceH)ar more than are )ound in vaccines ivin# combined vaccines and multiple shots means )ewer needles
)or a child
Commonly asked FuestionsCommonly asked FuestionsCan too many vaccines overload a +a+yGsCan too many vaccines overload a +a+yGs
immune systemimmune system
C l k d tiCommonly asked Fuestions
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
75/93
2010 Canadian Paediatric Society I www.cps.ca
As lon# as a vaccine-preventable disease e'ists somewhere in the
world any unimmuni+ed child is at risk*
3 A traveller may brin# the disease to any area
3 A child may travel to an area where the disease is more common Vaccination does not #et rid o) some #erms &e#$ pneumococcus(
which may still be carried by older children and adults
Tetanus bacteria are present in soil and dust everywhere in theworld$ Any child can be in)ected )rom a dirty wound
Commonly asked FuestionsCommonly asked FuestionsSince most other children are vaccinatedSince most other children are vaccinated
and diseases are disa''earing, why +otherand diseases are disa''earing, why +othervaccinating my childvaccinating my child
Commonly asked FuestionsCommonly asked Fuestions
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
76/93
2010 Canadian Paediatric Society I www.cps.ca
For ma'imum protection complete vaccine series well be)ore
se'ual activity starts ;chool-based pro#rams more e))ective in reachin# tar#et
populations in primary school than in secondary school Loun#er children have a better immune response to the vaccine
Commonly asked FuestionsCommonly asked FuestionsWhy should my 'reteen +e vaccinatedWhy should my 'reteen +e vaccinated
against HPVagainst HPV
Commonly asked FuestionsCommonly asked Fuestions
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
77/93
2010 Canadian Paediatric Society I www.cps.ca
Inactivated vaccines do not contain live #erms and cannot cause the
in)ections they protect a#ainst "ive vaccines contain viruses that have been chan#ed so that they
are very weak and unable to cause disease in healthy people$:arely they may cause a very mild )orm o) the in)ection$ 1hildren
with certain immune system disorders may develop an in)ection
with these vaccines and should not receive them
Commonly asked FuestionsCommonly asked FuestionsCan vaccines cause the infection they areCan vaccines cause the infection they are
su''osed to 'reventsu''osed to 'revent
S ki i h +
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
78/93
S'eaking with 'arents a+outS'eaking with 'arents a+out
vaccinationvaccination
2010 Canadian Paediatric Society I www.cps.ca
"isten evaluate and cate#ori+e :eco#ni+e le#itimate concerns 2rovide conte't
:e)ute misin)ormation 2rovide valid in)ormation :eco#ni+e that immuni+in# is a parents decision >ducate about potential consequences o) the decision Make a clear recommendation
Source: Dr. Scott A. Halperin, Dalhousie Universit, !anadian "ournal of !#$, "anuar %&&&
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
79/93
Pu+lic 'olicyPu+lic 'olicy
2010 Canadian Paediatric Society I www.cps.ca
+li fP +li t f
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
80/93
In 96.6 .@ vaccines are publicly )unded by all provincesBterritories ;chedules )or some publicly )unded pro#ramsHmenin#ococcal
con
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
81/93
1anadas roadmap )or ensurin# vaccine access supply sa)ety and
e))icacy >stablished in 9664 with )ive mandates*
3 ?evelop national #oals and recommendations )or immuni+ation
pro#rams
3 Immuni+ation pro#ram plannin#
3 Vaccine sa)ety
3 Vaccine supply
3 An immuni+ation re#istry network 1ross-cuttin# issues* immuni+ation research pro)essional and public
education special populations &immi#rants re)u#ees travellers and
First ,ations and Inuit( and vaccine-preventable disease surveillance
5ational Immunization5ational Immunization
Strategy 75IS8Strategy 75IS8
2010 Canadian Paediatric Society I www.cps.ca
d SP t d 5IS
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
82/93
9664* "aunched with S@5 million over )ive years to improve
1anadas vaccination pro#rams and S49 million over )ive years )or anational on-reserve immuni+ation strate#y$ 2art o) a S.$4-billion
pro#ram )or First ,ations and Inuit health 966@* Another S466 million over three years )or vaccine
procurement to allow the provincesBterritories to add newly
recommended vaccines to publicly )unded pro#rams 9660* Federal #overnment created a trust )und )or three years )or
provincesBterritories to initiate E2V pro#ram Further advocacy is needed to ensure other vaccines continue to have
support Federal #overnment currently provides some annual )undin# to
improve e))ectiveness and e))iciency o) immuni+ation pro#rams in
1anada
Progress toward 5ISProgress toward 5IS
2010 Canadian Paediatric Society I www.cps.ca
C ll iC ll t ti
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
83/93
2rovide sustained )undin# and support )or a comprehensive ,ationalImmuni+ation ;trate#y
2rovide sustained )undin# to the provinces and territories to allow
them to o))er newly recommended vaccines at no cost to the public ?evelop a national immuni+ation re#istry to track numbers o)
children and youth who are receivin# vaccines$ Ideally this re#istrywould include electronic record-keepin# )unctions )or easy
transmission and monitorin# and )or makin# sure every childs
schedule is up-to-date ;tandardi+e immuni+ation schedule across 1anada
>nsure the involvement o) non#overnmental and pro)essionalor#ani+ations such as the 12; with e'pertise in immuni+ation
Calls to actionCalls to action
2010 Canadian Paediatric Society I www.cps.ca
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
84/93
;esources;esources
2010 Canadian Paediatric Society I www.cps.ca
P f i l l iP f i l l i
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
85/93
Professional learningProfessional learning
2010 Canadian Paediatric Society I www.cps.ca
Immunization Competencies for
Health Professionals
2ublished by the
2ublic Eealth A#ency o) 1anada
in ,ovember 9667
www$phac-aspc$#c$caBimBpd)Bichp-cips-en#$pd)
Immunization Competencies or HealthImmunization Competencies or Health
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
86/93
2010 Canadian Paediatric Society I www.cps.ca
) >ssential knowled#e and skills )or e))ective immuni+ation ?eveloped to support the ,ational uidelines )or Immuni+ation
2ractices published in the !anadian 'mmunization (uide 1an be adapted and incorporated into all immuni+ation trainin# or
per)ormance evaluations
3 To educate health pro)essionals involved in immuni+ation3 To promote sa)e and competent practices
Immunization Competencies or HealthImmunization Competencies or Health
ProessionalsProessionals
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
87/93
Immunization Com'etencies >ducation ProgramImmunization Com'etencies >ducation Program
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
88/93
Immunization Com'etencies >ducation ProgramImmunization Com'etencies >ducation Program
3n online course for health professionals) developed by +(& and the (ublic ;ealth 3gency
of +anada) is available at ###"cps"ca45nglish4(ro5du49nline5du"htm
Multidisciplinary* to meet the needs o) the #rowin# number wider ran#e o) health pro)essionals
involved in administerin# vaccines
1ourse desi#ned to* build immuni+ation skills and knowled#e promote public con)idence around vaccine e))ectiveness and delivery and )oster relationships amon# health pro)essionals unaccustomed to workin# to#ether
%asic competencies* how vaccines work the rationale and bene)its o) immuni+ation the main steps in vaccine development and evaluation
the components and properties o) immuni+in# a#ents principles o) population health )or improvin# covera#e rates
>ach competency is supported by a learnin# domain and a number o) #uidin# learnin# ob
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
89/93
Immunization we+sitesImmunization we+sites
for 'rofessionals and 'arentsfor 'rofessionals and 'arents 1anadian 2aediatric ;ociety* www$cps$ca Eealth 1anada 2ublic Eealth A#ency o) 1anada*
www$phac-aspc$#c$caBimBinde'$html ,ational Advisory 1ommittee on Immuni+ation* www$naci$#c$ca
1anadian 1oalition )or Immuni+ation Awareness and 2romotion*www$immuni+e$cpha$ca
American Academy o) 2ediatrics* www$aap$or# 1enters )or ?isease 1ontrol and 2revention* www$cdc$#ov Advisory 1ommittee on Immuni+ation 2ractices &A1I2(
www$cdc$#ovBvaccinesBrecsBA1I2Bde)ault$htm Immuni+ation Action 1oalition* www$immuni+e$or# Institute o) Medicine* www$iom$edu
2010 Canadian Paediatric Society I www.cps.ca
Assessing vaccineAssessing vaccine
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
90/93
Assessing vaccineAssessing vaccine
information on the Internetinformation on the InternetAskin# a )ew key questions can help you tell whether or not you can trust the
in)ormation you )ind on the Internet*
.$ Ghat is the source o) the in)ormation ?oes the site* Identi)y who has produced the in)ormation
"ist all sources o) )undin# 2rovide a way to contact the provider o) in)ormation
9$ Eas the medical in)ormation been reviewed by scienti)ic e'perts
4$ Is there a date showin# when the in)ormation was posted online andBor last
revised
@$ Is there scienti)ic evidence to back up the claims &e$#$ articles )romrespected medical
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
91/93
) 1anadian 2aediatric ;ociety$ 4rdedn$ 9668$)our !hild*s +est Shot:
A arent*s (uide to -accination. 1anadian 2aediatric ;ociety$ MM: vaccine* Myths and Facts$J
A tear-away pad )or in)ormin# )amilies$
Fisher Mar#aret 1$ &9668('mmunization and 'nfectious Diseases: An'nformed arent*s (uide$ >lk rove Villa#e Ill$* American Academy
o) 2ediatrics$ 2ublic Eealth A#ency o) 1anada$ 9667$'mmunization !ompetencies
for Health rofessionals.
2ublic Eealth A#ency o) 1anada$ 966/$A arent*s (uide to-accination$
2ublic Eealth A#ency o) 1anada$ !anadian 'mmunization (uide$
7thedn$ 96.6$
2010 Canadian Paediatric Society I www.cps.ca
3ooks and 'rinta+le resources3ooks and 'rinta+le resources
for 'rofessionals and 'arentsfor 'rofessionals and 'arents
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
92/93
uestions Commentsuestions Comments
2010 Canadian Paediatric Society I www.cps.ca
1ea e +ehind materials1eave +ehind materials
8/9/2019 Pharm Vaccine Presentation for Power Point 97-2004
93/93
1eave+ehind materials1eave+ehind materials
A list o) resources and the routine immuni+ation schedule are
available as pd)s on the 12; website so users can printphotocopy and distribute )or their presentations at no cost$